Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Oncotarget
; 9(94): 36720-36721, 2018 11 30.
Article
en En
| MEDLINE
| ID: mdl-30613355
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Año:
2018
Tipo del documento:
Article